 |  |
| ABX | ||
| 2,543.007 | ||
| 33.4630 | 0.0133% | |
| BISNIS-27 | ||
| 552.996 | ||
| 2.3220 | 0.0042% | |
| DBX | ||
| 4,209.222 | ||
| 39.3220 | 0.0094% | |
| ECONOMIC30 | ||
| 116.184 | ||
| 0.2580 | 0.0022% | |
| ESGQKEHATI | ||
| 127.780 | ||
| 0.4070 | 0.0032% | |
| ESGSKEHATI | ||
| 128.407 | ||
| 0.6050 | 0.0047% | |
| I-GRADE | ||
| 232.727 | ||
| 1.5360 | 0.0066% | |
| AUDRP | ||
| 11,082.190 | ||
| 33.2400 | 0.3008% | |
| EURRP | ||
| 19,438.290 | ||
| 61.1100 | 0.3154% | |
| JPYRP | ||
| 107.544 | ||
| 0.3983 | 0.3717% | |
| SINRP | ||
| 12,875.340 | ||
| 38.9100 | 0.3031% | |
| USDRP | ||
| 16,680.000 | ||
| 35.0000 | 0.2103% | |
Penelitian terhadap vaksin nasional COVID-19, Vaksin Merah Putih, terus berlanjut, salah satunya oleh tim peneliti Universitas Airlangga bersama PT Biotis Pharmaceutical Indonesia. Penelitian vaksin telah memasuki uji praklinis tahap II.
